No evidence of disease activity in anti-JC virus seronegative patients with early relapsing-remitting multiple sclerosis treated with natalizumab: a prespecified 2-year analysis of STRIVE
MULTIPLE SCLEROSIS JOURNAL（2017）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要